Member Exclusive

Gene mutation may provide novel drug targets for rare kidney and liver disease

An international study team have investigated how mutations in the PKHD1 gene are associated with autosomal recessive polycystic kidney disease. These findings may help in the development of future treatment strategies.

Go to the profile of Peter Brown
Sep 07, 2017

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.